earnings, page-16

Scammer, don't worry about what the price reduction is compared to what the branded used to sell for, work it out from overall sales.

$1.67m per week = US$86.84m
$86.84m less 40% COGS = US$52.1m
50% profit share to ACL = US$26.05m
$26.05m divided into 281m shares outstanding = 9.27c EPS

The above is approx of course and assumes 40% COGS, Reddy's have said that the process is now refined and improved, well to that affect.

I notice on the 28th March Investor Presentation they said "1st revenues from fondaparinux expected Q2 2012", mmm maybe Pete was flagging something with his 60 day comment in the latest announcment:)

On an even brighter note, the above earnings should start to rise during this quarter and beyond:

"Commenting on the results during the Dr Reddy’s Q4 conference call, Satish Reddy, Managing Director and COO commented “We are pleased to see the improvements in the volumes of Fondaparinux leading to higher market share in the coming quarter, and we expect expanded market share in the coming quarters”. Also during the call, Dr Reddy’s commented that it has sufficient capacity to meet the demands of both the retail and hospital sectors in the US and is building additional capacity to meet demand for the EU where the product has recently been filed for approval"


GL all, just thoughts.